English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Advertisement
    Remove Ad
    HomeNewsBusinessStocksBuy Sanofi India; target of Rs 5330: Centrum

    Buy Sanofi India; target of Rs 5330: Centrum

    Centrum is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 5330 in its research report dated February 28, 2017.

    October 30, 2023 / 16:58 IST
    The Nifty Total Market Index: A Comprehensive Glimpse into India's Economic Landscape
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Centrum's report on Sanofi India

      The launch of new anti-diabetic products and line extensions are likely to drive future growth. We expect improved performance due to continued strong growth of its six flagship brands which grew faster than the market growth. SIL is among the top picks in the pharma sector.

      Outlook

      We retain our Buy rating on Sanofi India (SIL) and revise our TP to Rs 5,330 (earlier Rs 5,880) based on 25x December’18E EPS of Rs 213.4. SIL’s results for Q4CY16 were below our expectations and were impacted by demonetisation. The company’s revenue increased 4% YoY, margin declined 180bps to 18.1% and net profit fell 4%.

      For all recommendations, click here

      Story continues below Advertisement
      Remove Ad

      Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

      Check your Free Credit Score now Check your Free Credit Score now

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Advertisement
      Remove Ad

      Must Listen

      NPPA asks stent makers, importers to submit price list by Mar 1

      NPPA asks stent makers, importers to submit price list by Mar 1

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347